Работы, цитирующие эту работу

Работ: 5

Работа: The clinical landscape of CAR NK cells

1. Engineering CAR T NK and NKT cell therapies to target cancer stem cells and overcome stem like resistance

   Omer Qutaiba B. Allela, Abdulkareem Shareef, S. Renuka Jyothi +9

   СтатьяCAR-T cell therapy researchDiscover Oncology2025Цитирований: 0

   ABIABI:AkademIndex/openalex/2025.article.001466

2. Therapeutic targeting of cancer stem cell-specific surface glycans and glycoproteins

   Mutaz Jamal Al-khreisat, Waleed K. Abdulsahib, Ihsan Khudhair Jasim +6

   СтатьяGlycosylation and Glycoproteins ResearchDiscover Oncology2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.003592

3. Next-generation CAR-T and CAR-NK cell therapies in hematologic malignancies: engineering for persistence, specificity, and safety

   Mutaz Jamal Al-khreisat, Waleed K. Abdulsahib, Ihsan Khudhair Jasim +6

   СтатьяCAR-T cell therapy researchDiscover Oncology2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.005310

4. Natural killer cells, macrophages and dendritic cells as innate immune therapies for blood cancers

   Ghaleb Oriquat, Waleed K. Abdulsahib, Sajida Hussein Ismael +6

   СтатьяImmune Cell Function and InteractionAnnals of Hematology2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.005653

5. Emerging immune checkpoint targets and combination strategies in blood cancer immunotherapy

   Mutaz Jamal Al-khreisat, Waleed K. Abdulsahib, Ihsan Khudhair Jasim +6

   СтатьяCancer Immunotherapy and BiomarkersAnnals of Hematology2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.009488